SONMNasdaqTelephone & Telegraph ApparatusFiscal year ends December 31
DNA X, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$3.31+0.04 (+1.22%)
Close on Oct 19, 2026
- Market cap
- $4.47M
- P/E (TTM)
- –
- Dividend yield
- –
DNA X, Inc. revenue by segment
By business segment
By product or service
| Revenue | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | Q2 23 | Q1 23 | Q4 22 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Smartphones | $8.11M | $4.84M | $11.03M | $6.39M | $7.96M | $6.37M | $5.58M | $7.73M | $8.36M | $8.87M | $6.49M | $6.81M | 50.0% | +1.9% |
| Connected Solutions | $4.00M | $2.25M | $689.00K | $3.10M | $49.00K | – | – | – | – | – | – | – | 24.7% | +8063.3% |
| Feature Phones | $3.80M | $3.84M | $4.81M | $5.63M | $6.78M | $4.71M | $3.35M | $4.03M | $4.91M | $3.01M | $3.85M | $1.63M | 23.4% | -43.9% |
| Accessories and Other | $305.00K | $270.00K | $190.00K | $152.00K | $236.00K | $433.00K | $188.00K | $721.00K | $425.00K | $217.00K | $207.00K | $72.00K | 1.9% | +29.2% |
| Product [Member] | – | – | – | $14.98M | $15.02M | $11.51M | $16.77M | $13.43M | $27.57M | $26.83M | $25.80M | $24.11M | – | – |
| Service [Member] | – | – | – | $0 | $1.00K | $4.00K | $3.00K | $3.00K | $1.00K | $1.00K | – | $5.00K | – | – |
| Tablets [Member] | – | – | – | – | – | – | – | – | – | – | – | $14.34M | – | – |
| Tablets [Member] | – | – | – | – | – | – | – | – | $13.87M | $14.74M | $15.26M | – | – | – |
| White Label Phones and Tablets | – | – | – | – | – | $0 | $7.66M | – | – | $14.74M | $15.26M | – | – | – |
| White Label Tablets | – | – | – | – | – | – | – | $954.00K | $13.87M | – | – | – | – | – |
By region
| Revenue | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | Q2 23 | Q1 23 | Q4 22 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $11.76M | $9.69M | $12.77M | $11.73M | $11.67M | $9.07M | $7.27M | $8.00M | $11.80M | $8.24M | $5.51M | $5.16M | 72.5% | +0.8% |
| Canada | $2.62M | $453.00K | $2.38M | $1.74M | $3.18M | $2.38M | $1.81M | $3.10M | $1.71M | $3.03M | $2.74M | – | 16.1% | -17.7% |
| Europe and Middle East | $1.82M | $1.01M | $1.04M | $522.00K | $77.00K | $2.00K | $41.00K | $1.30M | $87.00K | $829.00K | $2.08M | $43.00K | 11.2% | +2268.8% |
| Asia Pacific | $10.00K | $42.00K | $529.00K | $998.00K | $98.00K | $70.00K | $7.66M | $1.04M | $13.98M | $14.74M | $15.47M | $16.07M | 0.1% | -89.8% |
| Canada and Latin America | – | – | – | – | – | – | – | $3.10M | $1.71M | $3.03M | $2.74M | $2.84M | – | – |
From the segment and revenue-disaggregation notes of DNA X's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.